Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: Results of intergroup 0159/cancer and leukemia group B 9480 Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Agents
  • Prostatic Neoplasms
  • Quality of Life
  • Suramin

abstract

  • The pattern of results suggests that the lowest dose of suramin administered had a palliative effect in terms of improvement in QOL and decreased levels of depression and that this effect was lost once suramin was discontinued.

publication date

  • November 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20655

PubMed ID

  • 15484217

Additional Document Info

start page

  • 2202

end page

  • 8

volume

  • 101

number

  • 10